A Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UC (NCT05611671)

🧪 Interventions in This Study

• MORF-057 (DRUG)
• Placebo (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (102 Sites)

Showing the first 25 of 102 sites.

• Arizona Digestive Health - Sun City — Sun City, Arizona
• Gastro Care Institute — Lancaster, California
• TLC Clinical Research Inc. — Los Angeles, California
• Innova Clinical Trials — Coral Gables, Florida
• Eminat, LLC - Miramar — Miramar, Florida
• Robert Wood Johnson University Medical School — New Brunswick, New Jersey
• Great Lakes Gastroenterology — Mentor, Ohio
• The University of Texas Health Science Center at Houston — Houston, Texas
• Blacktown Hospital — Blacktown,
• Concord Repatriation General Hospital — Concord,
• Royal Brisbane and Women's Hospital — Herston,
• Fiona Stanley Hospital — Murdoch,
• Mater Adult Hospital Brisbane — South Brisbane,
• Order Hospital Linz Ltd. - Hospital of Sisters of Mercy — Linz,
• Salzburg Regional Hospital — Salzburg,
• Medical University of Vienna — Vienna,
• Medical Center "Rusemed" EOOD — Rousse,
• University Multiprofile Hospital for Active Treatment "ACIBADEM City Clinic" — Sofia,
• Acibadem City Clinic Multiprofile Hospital for Active Treatment Tokuda — Sofia,
• Second Multiprofile Hospital for Active Treatment - Sofia — Sofia,
• PreventaMed, s.r.o. — Olomouc,
• Clinoxus s.r.o., Outpatient Clinic Budejovicka — Prague,
• LV Venter OU — Pärnu,
• OU Innomedica — Tallinn,
• East Tallinn Central Hospital — Tallinn,

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Inflammatory Bowel Diseases

• Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care — Vancouver, British Columbia
• PRecisiOn Microbiome Directed ExtensiOn of Anti-TNFα Crohn's Disease ThErapy in Children: The PROMOTE Trial — Ottawa, Ontario
• A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy — Baltimore, Maryland
• Outpatient VR (Virtual Reality)-Brain-gut Behavioral Therapies (BGBT) in Inflammatory Bowel Disease (IBD) — Ann Arbor, Michigan
• A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease — Lancaster, California

Explore by condition: All Inflammatory Bowel Diseases clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.